~~<i id='6B335E8754'><strike id='6B335E8754'><tt id='6B335E8754'><pre id='6B335E8754'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

leisure time

knowledge

author：entertainment 2025-09-27 22:47:29 - browse：566

Senate health committee Chair Bernie Sanders — Sen. Berne Sanders (I-Vt.) Kevin Dietsch/Getty Images

WASHINGTON — Sen. Bernie Sanders (I-Vt.) has a new corporate target: the food industry.

Sanders held a hearing today on diabetes that implicated both the food and drug industries in what the American Diabetes Association estimates is a $413 billion annual cost to the health care system. That’s up 27% over the past six years, he said, and he warned that new weight loss drugs could send health care spending to the stratosphere.

But the food industry received more attention, especially from Sanders, than the drugmakers and drug middlemen.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The Supreme Court will review a ruling striking down a domestic violence federal gun ban
Next article： Physician executives need more than on

explore

entertainment

focus

hotspot

AdobeTheshortageofcancerdrugsisnotgoingaway,butitmaybeeasingslightly,anewnationalsurveysuggests.Base

WSS

Readout Newsletter: What happened with Sarepta's Duchenne data

VC firm General Catalyst wants to buy a health system

Medtronic CEO on promising devices for diabetes, hypertension

Medtronic CEO on promising devices for diabetes, hypertension

First Opinion Podcast: How to protect health care in times of war

FDA has safety concerns on CRISPR

leisure time

knowledge

explore

Novavax promises a turnaround & Lilly roils the obesity market

A Q&A with the global head of Boehringer Ingelheim's innovation unit

Malaria cases in Florida and Texas: Here’s what you need to know

Readout Newsletter: The latest from Bristol, Sarepta, and Novartis

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Testing for cancer recurrence creates a new limbo for patients

Medical records are filled with copy

VC firm General Catalyst wants to buy a health system

New air purifier tech could be key to improving indoor air quality

Medtronic CEO on promising devices for diabetes, hypertension

explore

Telehealth options flood the market as retailers push virtual care

Biden's order seeks to regulate AI risk without stifling innovation

Biden's order seeks to regulate AI risk without stifling innovation

STAT Wunderkinds: Ruey Hu's digital tools for parsing research

Was Amgen transparent enough on FDA's concern on cancer drug?

Diversifying clinical trials isn't enough to close racial gaps: study

entertainment

focus

focus

hotspot